Online ISSN: 2515-8260

Keywords : chest pain


A STUDY ON PERSISTENT SYMPTOMS IN PATIENTS WHO WERE DISCHARGED FROM A DEDICATED COVID HOSPITAL INTENSIVE CARE UNIT (ICU)

Dr. Hema.HA,Dr. Shruthi Jayaram, Dr. Ravi. S, Dr. Lakshmeesha.T

European Journal of Molecular & Clinical Medicine, 2021, Volume 8, Issue 4, Pages 2034-2039

Introduction: A significant proportion of patients who had COVID-19 have experienced symptoms persisting even weeks after recovery from the acute phase of infection. For some patients the symptoms were mild but few have experienced moderate to severe symptoms hampering their daily routine. Studies to know the long term effects of COVID-19 are needed to effectively plan healthcare delivery.
Aim: To know the persistent symptoms in patients who were discharged from a dedicated COVIDhospital’s intensive care unit (ICU).
Materials and Methods: In this cohort studyfour hundred and forty six patients with laboratory confirmed COVID 19, who were treated and discharged from intensive care unit(ICU) between April 2019 to Nov 2019 were included. The telephonic survey was done four times in three months after being discharged. First follow up was on the15th day of discharge, second on the first month of discharge, third follow up on the second month of discharge and the fourth at the end of third month. Patients were asked to retrospectively recollect the symptoms which were present during the acute phase of the disease and if those symptoms or any new symptoms are present now.
Results: Tiredness(fatigue), dyspnea, cough and chest pain were the common symptoms observed. Among 446 patients followed up, 37.4% had no symptoms at the first follow up and 87% were symptom free by the end of third month. 26.09% complained of tiredness at the 15th day of discharge, but only 4.4% of them complained of this symptom at the end of third month. Dyspnea was seen in 21.5% of patients in the first follow up and by the end of third month none of them had dyspnea. There was a gradual decline in number of patients having cough from 19.5% in the first follow up to 0.24% in the last follow up. Chest pain was seen in 7% of the patients on the 15th day of discharge and was seen only in 0.24% of them at the end of third month. Out of 446 patients followed up for a period of three months we observed a mortality of 6.27%.
Conclusion: Patients experience persistent symptoms even after recovering from COVID 19infection and getting discharged from intensive care unit. There is a need for follow up and assessment of discharged patients to know to what extent these symptoms have affected them physically and mentally.
 

Assessment Of 120 Cases Of Pleural Effusion Underwent Medical Thoracoscopy

Jagpoornima Katoch; R. S. Negi; S. K. Sharma; Sunil Sharma; Malay Sarkar; Sanjeev Prabhakar; Ranjit Kaur

European Journal of Molecular & Clinical Medicine, 2021, Volume 8, Issue 1, Pages 1069-1074

Background: The present study was conducted to determine 120 cases of pleural effusion underwent medical thoracoscopy.
Materials & Methods: 120 patients who underwent medical thoracoscopy in 79 Males and 41 females were recruited. Diagnostic pleural aspiration was done and the pleural fluid was analyzed for sugar, protein, Lactate dehydrogenase (LDH), Adenosine deaminase (ADA), gram-stain, Acid-fast bacilli (AFB) smear, culture, CBNAAT, and cytological analysis. Patients with unhelpful results of pleural fluid analysis (Light’s criteria) underwent medical thoracoscopy and pleural biopsy.
Results: 98 (81.7%) had pleural effusion on (CE-CT) thorax as 6 (5%) had mass lesion on left side where 6 (5%) had lesion on right side, 10 (8.3%) had other findings like passive collapse, consolidation, atelectasis, mediastinal lymphadenopathy. 13 (10.8%) patients had edematous mucosa on FOB, 19 (15.85%) patients had external compression on FOB, whereas 77 (64.2%) had the normal study on bronchoscopy, whereas 11 (9.2%) had other findings like anthracotic patches. 38 (31.7%) had inflammation, sago grain like nodules, adhesions on thoracoscopy, 25 (20.8%) had inflammation and adhesions, 51 (42.5%) had inflammation with nodules/masses/plaques, 2 (1.7%) had necrotic/ulcerative/other lesions on thoracoscopy. Conclusion: Medical diagnostic thoracoscopy should be considered in all patients having undiagnosed pleural effusion and fit for medical thoracoscopy